A detailed history of Cibc Asset Management Inc transactions in Catalent, Inc. stock. As of the latest transaction made, Cibc Asset Management Inc holds 25,173 shares of CTLT stock, worth $1.48 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
25,173
Previous 23,327 7.91%
Holding current value
$1.48 Million
Previous $1.31 Million 16.25%
% of portfolio
0.01%
Previous 0.01%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$56.16 - $60.96 $103,671 - $112,532
1,846 Added 7.91%
25,173 $1.52 Million
Q2 2024

Aug 01, 2024

SELL
$53.58 - $57.02 $70,993 - $75,551
-1,325 Reduced 5.37%
23,327 $1.31 Million
Q1 2024

May 09, 2024

BUY
$42.56 - $59.82 $34,260 - $48,155
805 Added 3.38%
24,652 $1.39 Million
Q4 2023

Feb 13, 2024

SELL
$32.18 - $46.57 $51,648 - $74,744
-1,605 Reduced 6.31%
23,847 $1.07 Million
Q3 2023

Oct 30, 2023

SELL
$44.2 - $50.2 $9,237 - $10,491
-209 Reduced 0.81%
25,452 $1.16 Million
Q2 2023

Aug 14, 2023

SELL
$31.86 - $67.26 $8,060 - $17,016
-253 Reduced 0.98%
25,661 $1.11 Million
Q1 2023

May 12, 2023

BUY
$45.44 - $74.26 $15,404 - $25,174
339 Added 1.33%
25,914 $1.7 Million
Q4 2022

Feb 13, 2023

BUY
$41.39 - $81.0 $92,630 - $181,278
2,238 Added 9.59%
25,575 $1.15 Million
Q3 2022

Nov 03, 2022

BUY
$72.36 - $113.1 $159,409 - $249,159
2,203 Added 10.42%
23,337 $1.69 Million
Q2 2022

Aug 09, 2022

BUY
$87.2 - $114.05 $411,235 - $537,859
4,716 Added 28.72%
21,134 $2.27 Million
Q1 2022

May 06, 2022

BUY
$94.19 - $124.49 $33,249 - $43,944
353 Added 2.2%
16,418 $1.82 Million
Q4 2021

Feb 08, 2022

BUY
$119.57 - $139.07 $103,188 - $120,017
863 Added 5.68%
16,065 $2.06 Million
Q3 2021

Nov 09, 2021

BUY
$109.17 - $142.35 $75,436 - $98,363
691 Added 4.76%
15,202 $2.02 Million
Q2 2021

Aug 16, 2021

BUY
$100.34 - $115.69 $40,035 - $46,160
399 Added 2.83%
14,511 $1.57 Million
Q1 2021

May 14, 2021

BUY
$101.51 - $125.27 $73,391 - $90,570
723 Added 5.4%
14,112 $1.49 Million
Q3 2020

Nov 05, 2020

BUY
$72.74 - $92.5 $589,484 - $749,620
8,104 Added 153.34%
13,389 $1.15 Million
Q4 2019

Feb 14, 2020

BUY
$47.06 - $56.64 $24,800 - $29,849
527 Added 11.08%
5,285 $298,000
Q2 2019

Aug 05, 2019

BUY
$39.26 - $54.21 $186,799 - $257,931
4,758 New
4,758 $258,000
Q4 2018

Feb 12, 2019

SELL
$29.95 - $46.34 $142,502 - $220,485
-4,758 Closed
0 $0
Q3 2018

Nov 02, 2018

BUY
$40.12 - $45.55 $190,890 - $216,726
4,758 New
4,758 $217,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $10.6B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Cibc Asset Management Inc Portfolio

Follow Cibc Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Asset Management Inc with notifications on news.